Immatics Announces First Bristol Myers Squibb Opt-in of TCR-T Candidate from Ongoing Multi-target Strategic Collaboration
Bristol Myers Squibb exercised its first option and entered into a global license agreement with Immatics for the most a…
Bristol Myers Squibb exercised its first option and entered into a global license agreement with Immatics for the most a…
ImmunOs Therapeutics AG, a biopharmaceutical company leveraging its HLA-based technology platform to develop first-in-cl…
From May 22 to 24, 2019, PicoQuant held its second international symposium on “Single Photon Based Quantum Technologies”…
Quantum communication protects data transmission in an encrypted way that no longer leaves eavesdropping attempts undete…
apoplex medical technologies have now agreed a cooperation to jointly inform about the SRA (Stroke Risk Analysis) techno…
Cardior Pharmaceuticals has completed a EUR 15 million Series A financing round led by LSP (Life Sciences Partners), Boe…
“One of the most informative and interactive symposia of recent years,“ said WITec CEO Dr. Joachim Koenen about the 13th…
The EU-funded robotics project ECHORD++ has opened is first competitive call for experiment proposals. The aim of ECHORD…
. - Collaboration to expand label of QIAGEN's FDA-approved therascreen® EGFR RGQ PCR Kit and creates framework for long…
. - U.S. launch of therascreen EGFR RGQ PCR Kit (therascreen EGFR test) follows FDA approval of system to select non-sm…